Let's dive in because the markets are open and there's no time to waste today...

StockWireNews

Nasdaq Medtech Idea (BSGM) Has Major Analyst Coverage And Other Potential Driver Indicators To Know Now

2 Analysts Provide Consensus $10.00 Price Target

Here's Why You Need To Get This Profile On Your Radar Now...

January 12th

Good Morning,

Let's dive in because the markets are open and there's no time to waste today...

In the past month, I've delivered 3 separate Nasdaq short-term breakout ideas:

1.) VUZI ran from $5.65 and to a high of $11.00 one week for a new 52-week high and a run of approximately 94%.

2.) GNPX blazed its way to a new 9-month high of $5.72 after opening at $4.10 for a run of approximately 39% intraday.

3.) USAU opened at $13.92 and ran to a high of $17.40 within 1 week for a new 52-week high and a short-term move of approximately 25%.

Now, I want you to turn to a new Nasdaq profile out of the Medtech sector.

In case you weren't in the know, the medical devices market reached nearly $456.9Bn in 2019, having increased at a compound annual growth rate (CAGR) of 4.4% since 2015.

The market is expected to grow at a CAGR of 6.1% from 2021 and reach $603.5Bn in 2023.

For these reasons and more that I'll highlight in this report, there is only one profile to have on your radar today:

BioSig Technologies, Inc. (BSGM)

BioSig Technologies is a medical technology company commercializing a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals.

The company’s first product, PURE EP System is a computerized system intended for acquiring, digitizing, amplifying, filtering, measuring and calculating, displaying, recording and storing of electrocardiographic and intracardiac signals for patients undergoing electrophysiology (EP) procedures in an EP laboratory.

The Future Of Bioelectronic Medicine

Bioelectronic medicine, a diverse $20Bn market, explores how targeted electrical signals can harness the body’s natural mechanisms to diagnose and treat a range of diseases that currently have a high unmet need.

In fact, it is expected to help diagnose and treat diseases within neurology, auto-immune diseases, diabetes, arthritis, hypertension, pain management, cancer, and others. Including familiar devices, such as pacemakers, and emerging technologies, such as vagus nerve stimulators and implantable neurostimulators.

The field is making rapid strides attracting interest and investment from major players in technology and healthcare, such as Abbott Laboratories (NYSE: ABT), Medtronic, Inc. (NYSE: MDT), and Johnson & Johnson (NYSE: JNJ).

This is why this recent news could become a major catalyst for BSGM in the short-term...

No. 1 Potential BSGM Driver Indicator - Commercial Milestone

BioSig Announces First Sale Of Cardiac Signal Processing Systems

BioSig Technologies Inc (NASDAQ: BSGM), a medical device company, announced Friday a commercial milestone with respect to its FDA-approved PURE EP Systems.

What Happened: Westport, Connecticut-based BioSig said it sold three PURE EP Systems to St. David's HealthCare of Austin, Texas.

The PURE EP System is a proprietary signal acquisition and processing technology that is used for acquiring and storing electrocardiographic and intracardiac signals for patients undergoing electrophysiology procedures in a lab under the supervision of licensed health care practitioners who are responsible for interpreting the data.

The PURE EP System received FDA 510(k) market clearance in August 2018. A 510(k) clearance is given by the FDA to signal the device in question is substantially equivalent to a predicate device, such as a product already cleared for sale in the U.S.

Why It's Important: BioSig installed the first PURE EP System at St. David's Medical Center in November 2019, as part of a clinical trial, with the center's Texas Cardiac Arrhythmia Institute conducting the first patient cases.

To date, more than 400 patient procedures have been conducted with the PURE EP System across six clinical sites in the U.S., BioSig said.

"Our first commercial sale to St. David's HealthCare is another important milestone as we proceed in expanding our clinical footprint nationwide," CEO Kenneth Londoner said in a statement.

"This installation cements our valued relationship with St. David's and adds to the traction we are gaining in the electrophysiology (EP) market."

Read the full article here.

-----

No. 2 BSGM Potential Driver Indicator - Insider Buying

Insider Buys BioSig Technologies Stock

BioSig Technologies Inc (NASDAQ:BSGM) was trading 3.2% higher from the previous closing price. *Londoner Kenneth L filed a Form 4 with the SEC on Wednesday, December 2. The insider bought 2,000 shares at an average price of $4.65. After the transaction, the executive's stake in BioSig Technologies Inc. moved to 1,345,558 shares.

The Importance of Insider Transactions

While transactions from an insider shouldn't be used as the sole item to make an investment or trading decision, an insider buying or selling stock in their company can be a good added factor that leads to more conviction in a decision.

When an insider buys stock after an important sell off, that can indicate the insider's faith in the success of the organization. Henceforth, if the stock is bought at new highs, it might be because the insider feels that the stock is not overvalued. Conversely, insiders who are selling stock at new lows can potentially indicate some kind of capitulation moment. Insiders selling at new highs can indicate that exec wants to "take some profit" and "lock in a gain."

Read the full article here.

-----

No. 3 Potential BSGM Driver Indicator - Strong Analyst Coverage

Two different analysts have provided BSGM with targets of $9.00 and $11.00.

According to MarketBeat, Roth Capital provided BSGM with a target of $9.00 back on March 30th, 2020. From Monday's close of $XXX, that provides BSGM with upside potential of XXX%.

Also, the website reports Laidlaw Capital Markets to have tagged BSGM with a price target of $11.00 back on February 20th, 2019. From Monday's close of $XXX, that provides BSGM with upside potential of XXX%.

Now, I'm not saying that BSGM will be surging to those levels today, but there is major analyst upside potential you need to pay attention to on this Nasdaq Medtech idea.

-----

No. 4 BSGM Potential Driver Indicator - Shareholder Update

In October, the company released a shareholder update to provide key info on where the company is and where they will be heading in 2021 and beyond.

Here are some of the highlights:

  • Updates on the PURE EP™ System, which was recently installed at Massachusetts General Hospital (MGH) and the Hospital of the University of Pennsylvania for evaluation – two major clinical and research hubs on the East Coast, regarded for their outstanding contributions to medical innovation. The company reports that several other clinical sites are due to receive BioSig’s technology in the coming months, and the Company is on track to install PURE EP™ in up to ten hospitals across the country by year-end.
  • The Company’s experienced clinical and commercial team is paving the way towards sales and revenues, continuing to engage more clinical sites, conduct new installations for technology evaluations and clinical data collection, and drive physician engagement.
  • BioSig recently announced the acceptance of two manuscripts, including a study abstract featuring robust clinical data collected with the PURE EP™ System. The data were reviewed in a blinded, independent analysis and presented at the European Society of Cardiology’s ESC Congress 2020.
  • In 2020, BioSig raised $39Mn and, as of June 30, 2020, had $36.9Mn in cash on its balance sheet, placing it in the strongest financial position of its corporate history.

"We believe that BioSig is in a strong position to expand our business headed into 2021,” stated Kenneth L. Londoner, Founder, Chairman, and CEO of BioSig Technologies, Inc. “We entered the final stretch of 2020 with a healthy balance sheet with ample cash and no debt and notable corporate and clinical achievements, including new evaluative deployments of the PURE EP™ System at leading medical centers across the country. The strength of our sales and marketing team allows us to drive commercial adoption of the PURE EP™ System. At the same time, we continue developing an additional product pipeline to complement our core technology further and strengthen its competitive positioning for years to come. Our company demonstrated strong operational progress in some of the most challenging economic and social conditions, delivering on multiple catalysts in 2020 and building a foundation for robust growth in 2021."

Read the full letter here.

-----

No. 5 Potential BSGM Driver Indicator - Low Float

According to Yahoo Finance, BSGM has a small float.

The website reports this profile to have 23.57Mn shares in its float.

Why is that important? It's important on one crucial level. Volatility.

With so few shares available for trading, potential driver indicators can send shares heading vertical in the short-term.

-----

More About BioSig Technologies, Inc. (BSGM)

From the company website:

BioSig: A Pioneer in Signal Processing Solutions

At BioSig, we're working to develop and deliver the advanced signal processing solutions that will unlock the future of bioelectronic medicine, starting with the PURE EP™ System.

We built BioSig to achieve this vision – with a strong commitment to research, a world-class leadership team, and a network of expert partners. We are now achieving important milestones as we prepare to enter the fast-growing electrophysiology market, but our aspirations reach even further: to lead one of the most innovative and most promising frontiers in healthcare.

image

The PURE EP™ System elevates the standard of care in electrophysiology through enhanced signal acquisition, digital signal processing, and analysis. The PURE EP™ System is powered by a unique hardware architecture allowing the full range of cardiac analog signals to be acquired in a raw, streamlined, unfiltered format. This is then converted into a digital modality powered by advanced signal processing software for unlimited real time data analysis.

The PURE EP™ System is engineered around 5 unique main system capabilities providing clear and detailed signals across the entire range of cardiac frequencies.

Low-Noise Proprietary Architecture

Acquisition of high fidelity cardiac analog signals in an original unfiltered format.

Wide Dynamic Range

Retains cardiac signal details in 24-bit precision over the full range of 500mV.

Large Frequency Bandwidth

Allows high frequency cardiac signals to be accurately displayed.

Linear Signal Acquisition

Maintains the original signal amplitude (minimizes signal attenuation) even at higher frequencies.

Modular Design

Offers the possibility to upgrade with upcoming clinical modules and advanced Data-Enabled Software applications.

The PURE EP™ System is compatible with existing EP Lab equipment, providing ease-of-use and preserving current clinical workflow.

RAW SIGNAL ACQUISITION

Preserved Signal Integrity

The proprietary low-noise hardware architecture of the PURE EP™ System allows the full range of cardiac analog signals to be acquired in a raw, streamlined, unfiltered format. The result is an ultra-high resolution of the raw signals.

SOFTWARE SIGNAL PROCESSING

Unparalleled Signal Fidelity and Real-Time Analysis

Advanced signal processing software converts the raw data set into a digital modality, enabling unlimited real-time data analysis.

USER CONTROL INTERFACE

Customized to Your Clinical Needs

Users can gain a deeper understanding of the signals by zooming in and magnifying multi- factorial components of the electrogram. They can also apply custom filters that focus on high-frequency signals while maintaining full visualization of higher-amplitude electrograms.

-----

Top 5 BSGM Potential Driver Indicators Recap

#1. Announcement Of First Sale Of PURE EP™ System

#2. Insider Buying On BSGM

#3. Strong Analyst Coverage With 2 Major Price Targets

#4. Recent Shareholder Letter With 2020 Updates And More

#5. BSGM's Low Float

-----

image

If there are any updates today, I'll get them out to you quickly.

Sincerely,

Kai Parker

StockWireNews


Source 1

Source 2

Source 3


(Always Remember The Stock Prices Could Be Significantly Lower Now From The Dates I Provided.)

Disclosure: I am not a lice.nsed finan.cial adviser. All potential percentage gains are based on from the low to the high of day. StockWireNews full disclosure is to be read and fully understood before using StockWireNews website, or joining StockWireNews' email or text list. By viewing StockWireNews website and/or reading Stock Wire News email or text newsletter you are agreeing to StockWireNews full disclosure which can be read at www.stockwirenews.net/disclosure StockWireNews (stock wire news . com) is owned by StockNewsWire LLC, a limited liability company. An owner of StockNewsWire, LLC owns an interest in the limited liability company that owns and operates small cap firm . com (“SCF”), an interest in the limited liability company that owns and operates fierceinvestor . com (“FI”), an interest in the limited liability company that owns and operates stockstreetwire . com (SSW), and an interest in the limited liability company that owns and operates nasdaq wire news . com (NWN) . From time to time, StockWireNews, SCF, FI, SSW, and/or NWN will publicly disseminate information about a company via website, email, SMS and other points of media. Pursuant to an agreement between StockNewsWire, LLC and Venado Media, LLC, StockWireNews has been hired for a one day period on 2/19/20 to publicly disseminate information about (BSGM) via Website, Email and SMS. We have been paid twenty-five thousand USD via bank wire transfer. We own zero shares of (BSGM). Pursuant to an agreement between StockNewsWire, LLC and Venado Media, LLC, StockWireNews has been paid an additional five thousand USD via bank wire transfer on 2/21/20 for continuing coverage of (BSGM). We own zero shares of (BSGM). Pursuant to an agreement between StockNewsWire, LLC and Venado Media, LLC, StockWireNews has been hired for a one day period on 4/9/20 to publicly disseminate information about (BSGM) via Website, Email and SMS. We have been paid seven thousand USD via bank wire transfer. We own zero shares of (BSGM). Pursuant to an agreement between StockNewsWire, LLC and Venado Media, LLC, StockWireNews has been hired for a one day period on 6/17/20 to publicly disseminate information about (BSGM) via Website, Email and SMS. We have been paid twenty-seven thousand five hundred USD via bank wire transfer. We own zero shares of (BSGM). Pursuant to an agreement between StockNewsWire, LLC and Legends Media, LLC, StockWireNews has been hired for a one day period on 1/12/21 to publicly disseminate information about (BSGM) via Website, Email and SMS. We have been paid twenty-seven thousand five hundred USD via bank wire transfer. We own zero shares of (BSGM). To date, we have been compensated a total of ninety-two thousand USD to disseminate information about (BSGM). Pursuant to an agreement between StockWireNews LLC and Venado Media LLC, StockWireNews was hired for a period beginning on 9/11/19 and ending on 9/12/19 to publicly disseminate information about (USAU) via Website, Email and SMS. We were paid twenty-five thousand USD via bank wire transfer. We own zero shares of (USAU). StockWireNews has been paid an additional seven thousand USD via bank wire transfer. Pursuant to an agreement between StockWireNews LLC and Venado Media LLC, StockWireNews was hired for a one day period beginning on 3/24/20 to publicly disseminate information about (USAU) via Website, Email and SMS. We were paid twenty-five thousand USD via bank wire transfer. We own zero shares of (USAU). StockWireNews has been paid an additional seven thousand USD via bank wire transfer. Pursuant to an agreement between StockWireNews LLC and Venado Media LLC, StockWireNews was hired for a one day period beginning on 3/26/20 to publicly disseminate information about (USAU) via Website, Email and SMS. We were paid seven thousand USD via bank wire transfer. We own zero shares of (USAU). Pursuant to an agreement between Stock News Wire LLC and Venado Media, LLC, StockWireNews has been hired for a one day period beginning on 8/13/20 to publicly disseminate information about (USAU) via Website, Email and SMS. We have been paid eighty thousand USD via bank wire transfer. We own zero shares of (USAU). Pursuant to an agreement between Stock News Wire LLC and Legends Media, LLC, StockWireNews has been hired for a one day period beginning on 9/10/20 to publicly disseminate information about (USAU) via Website, Email and SMS. We have been paid fifteen thousand USD via bank wire transfer. We own zero shares of (USAU). Pursuant to an agreement between Stock News Wire LLC and Legends Media, LLC, StockWireNews has been hired for a period beginning on 12/29/20 and ending on 12/30/20 to publicly disseminate information about (USAU) via Website, Email and SMS. We have been paid twenty-seven thousand five hundred USD via bank wire transfer. We own zero shares of (USAU). To date, we have now been compensated a total of one hundred and seventy-nine thousand five hundred USD via bank wire transfer to disseminate information about (USAU). Pursuant to an agreement between StockWireNews LLC and Venado Media, LLC, StockWireNews has been hired for a one day period on 5/8/20 to publicly disseminate information about (VUZI) via Website, Email and SMS. We have been paid twenty-seven thousand five hundred USD via bank wire transfer. We own zero shares of (VUZI). Pursuant to an agreement between StockWireNews LLC and Venado Media, LLC, StockWireNews has been hired for a period beginning on 7/16/20 and ending on 7/17/20 to publicly disseminate information about (VUZI) via Website, Email and SMS. We have been paid forty thousand USD via bank wire transfer. We own zero shares of (VUZI). Pursuant to an agreement between StockWireNews LLC and Venado Media, LLC, StockWireNews has been hired for a period beginning on 9/3/20 and ending on 9/4/20 to publicly disseminate information about (VUZI) via Website, Email and SMS. We have been paid fifteen thousand USD via bank wire transfer. We own zero shares of (VUZI). To date, we have been compensated a total of eighty-two thousand five hundred USD via bank wire transfer to disseminate information about (VUZI). Pursuant to an agreement between Stock News Wire LLC and Legends Media, LLC, StockWireNews has been hired for a period beginning on 12/16/20 and ending on 12/17/20 to publicly disseminate information about (VUZI) via Website, Email and SMS. We have been paid sixty-seven thousand five hundred USD via bank wire transfer. We own zero shares of (VUZI). To date, we have been compensated a total of one hundred and fifty thousand USD via bank wire transfer to disseminate information about (VUZI). Pursuant to an agreement between StockNewsWire, LLC and Venado Media, LLC, StockWireNews has been hired for a one day period on 1/21/20 to publicly disseminate information about (GNPX) via Website, Email and SMS. We have been paid twenty-two thousand five hundred USD via bank wire transfer. We own zero shares of (GNPX). Pursuant to an agreement between StockNewsWire, LLC and Venado Media, LLC, StockWireNews has been hired for a one day period on 2/11/20 to publicly disseminate information about (GNPX) via Website, Email and SMS. We have been paid forty-six thousand USD via bank wire transfer. We own zero shares of (GNPX). Pursuant to an agreement between StockNewsWire, LLC and Venado Media, LLC, StockWireNews has been hired for a one day period on 5/5/20 to publicly disseminate information about (GNPX) via Website, Email and SMS. We have been paid twenty-seven thousand five hundred USD via bank wire transfer. We own zero shares of (GNPX). Pursuant to an agreement between StockNewsWire, LLC and Venado Media, LLC, StockWireNews has been hired for a one day period on 6/4/20 to publicly disseminate information about (GNPX) via Website, Email and SMS. We have been paid twelve thousand five hundred USD via bank wire transfer. We own zero shares of (GNPX). Pursuant to an agreement between StockNewsWire, LLC and Venado Media, LLC, StockWireNews has been hired for a one day period on 7/22/20 to publicly disseminate information about (GNPX) via Website, Email and SMS. We have been paid twenty-seven thousand five hundred USD via bank wire transfer. We own zero shares of (GNPX). Pursuant to an agreement between StockNewsWire, LLC and Legends Media, LLC, StockWireNews has been hired for a period beginning on 10/29/20 and ending on 10/30/20 to publicly disseminate information about (GNPX) via Website, Email and SMS. We have been paid thirty-seven thousand five hundred USD via bank wire transfer. We own zero shares of (GNPX). Pursuant to an agreement between StockNewsWire, LLC and Legends Media, LLC, StockWireNews has been hired for a period beginning on 12/22/20 and ending on 12/23/20 to publicly disseminate information about (GNPX) via Website, Email and SMS. We have been paid seventeen thousand five hundred USD via bank wire transfer. We own zero shares of (GNPX). To date, we have now been compensated a total of one hundred ninety-one thousand USD to disseminate information about (GNPX).